[go: up one dir, main page]

FR20C1020I1 - PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT

Info

Publication number
FR20C1020I1
FR20C1020I1 FR20C1020C FR20C1020C FR20C1020I1 FR 20C1020 I1 FR20C1020 I1 FR 20C1020I1 FR 20C1020 C FR20C1020 C FR 20C1020C FR 20C1020 C FR20C1020 C FR 20C1020C FR 20C1020 I1 FR20C1020 I1 FR 20C1020I1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition containing
contraceptive kit
containing drospirenone
drospirenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR20C1020C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Leon Farma SA
Original Assignee
Laboratorios Leon Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42671710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1020(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Leon Farma SA filed Critical Laboratorios Leon Farma SA
Publication of FR20C1020I1 publication Critical patent/FR20C1020I1/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR20C1020C 2010-06-29 2020-06-11 PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT Active FR20C1020I1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28
EP11727985.1A EP2588114B1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit
PCT/EP2011/060795 WO2012000981A1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (1)

Publication Number Publication Date
FR20C1020I1 true FR20C1020I1 (en) 2020-08-07

Family

ID=42671710

Family Applications (2)

Application Number Title Priority Date Filing Date
FR20C1020C Active FR20C1020I1 (en) 2010-06-29 2020-06-11 PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT
FR22C1031C Active FR22C1031I2 (en) 2010-06-29 2022-06-23 PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR22C1031C Active FR22C1031I2 (en) 2010-06-29 2022-06-23 PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Country Status (25)

Country Link
US (9) US11452695B2 (en)
EP (3) EP3632448B1 (en)
JP (1) JP5810159B2 (en)
KR (3) KR102164693B1 (en)
AR (1) AR081670A1 (en)
BR (1) BR112012033391B1 (en)
CA (3) CA2803721C (en)
CY (2) CY1122544T1 (en)
DK (1) DK3632448T3 (en)
EA (1) EA028680B1 (en)
ES (1) ES2908657T3 (en)
FR (2) FR20C1020I1 (en)
HR (1) HRP20220332T1 (en)
HU (3) HUE058176T2 (en)
LT (2) LT3632448T (en)
NO (2) NO2020015I1 (en)
NZ (1) NZ605176A (en)
PE (2) PE20161410A1 (en)
PH (1) PH12012502499A1 (en)
PL (2) PL2588114T3 (en)
PT (1) PT3632448T (en)
RS (2) RS59826B1 (en)
SI (2) SI2588114T1 (en)
SM (2) SMT202000063T1 (en)
WO (1) WO2012000981A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081670A1 (en) 2010-06-29 2012-10-10 Leon Farma Sa Lab PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
MD3310346T2 (en) 2015-06-18 2021-06-30 Estetra Sprl Orodispersible tablet containing estetrol
JP6866560B2 (en) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ Orally disintegrating dosing unit containing an estetrol component
HUE054589T2 (en) 2015-06-18 2021-09-28 Estetra Sprl Orodispersible tablet containing estetrol
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
MX389310B (en) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa DROSPIRENONE-BASED CONTRACEPTIVES FOR FEMALE PATIENTS AFFECTED BY EXCESS WEIGHT.
KR102712911B1 (en) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 Method for the management of dysmenorrhea and menstrual pain
TWI801561B (en) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en) 2018-04-19 2019-10-19 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (en) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 Contraceptive compositions with reduced adverse effects
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
US20250186337A1 (en) 2022-03-01 2025-06-12 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (en) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE3022337A1 (en) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Compsns. for contraception or treatment of gynaecological disorders - contg. 6 beta, 7 beta; 15 delta, 16 beta-di:methylene-3-oxo-4-androstene-17(beta-1')-spiro-5'-per:hyd- ro-furan-2'-one
ES2078447T3 (en) 1990-06-15 1995-12-16 Merck & Co Inc A CRYSTALLIZATION PROCEDURE TO IMPROVE THE STRUCTURE AND SIZE OF CRYSTALS.
GB2256648B (en) 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
DE19633685C1 (en) 1996-08-12 1997-10-09 Schering Ag Production of drospirenone useful as steroidal agent
ES2319750T3 (en) 1999-08-31 2009-05-12 Bayer Schering Pharma Aktiengesellschaft PHARMACEUTICAL COMPOSITION THAT INCLUDES ETHYLINESTRADIOL AND DROSPIRENONE TO USE AS AN ANTI-CONCEPTIVE.
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
EE05533B1 (en) 2000-01-18 2012-04-16 Schering Aktiengesellschaft Pharmaceutical composition and preparation containing micronized drospirenone and 'strogen and their use
US20040087563A1 (en) 2002-11-05 2004-05-06 Siegfried Mayerhofer Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
EP1748756B1 (en) 2004-03-10 2009-04-29 Bayer Schering Pharma Aktiengesellschaft Compositions comprising drospirenone molecularly dispersed
US20050220825A1 (en) 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
MY151322A (en) 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1773344A1 (en) 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
EP1625849A1 (en) 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
ITMI20042338A1 (en) 2004-12-06 2005-03-06 Ind Chimica Srl PROCESS FOR THE PREPARATION OF DROSPIRENONE
US20060293295A1 (en) 2005-05-13 2006-12-28 Kai Strothmann Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
US8475838B2 (en) 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
TW200727920A (en) 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
ATE403668T1 (en) 2005-07-21 2008-08-15 Bayer Schering Pharma Ag METHOD FOR PRODUCING 3-OXO-PREGN-4-EN-21,17-CARBOLACTONES BY THE METAL-FREE OXIDATION OF 17-(3-HYDROXYPROPYL)-3,17-DIHYDROXYANDROSTANE
CN101489563A (en) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
CA2662956A1 (en) * 2006-09-16 2008-03-20 Bayer Schering Pharma Aktiengesellschaft Oral modified release formulations
US8741329B2 (en) 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
CN102006857B (en) 2008-02-13 2013-06-26 拜耳先灵医药股份有限公司 Drug delivery system with stabilising effect
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone
DE102008037025C5 (en) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Process for the preparation of crystalline drug microparticles or a solid state drug particle form
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (en) 2010-06-29 2012-10-10 Leon Farma Sa Lab PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

Also Published As

Publication number Publication date
US11491113B1 (en) 2022-11-08
KR20210013663A (en) 2021-02-04
KR102539030B1 (en) 2023-05-31
SMT202000063T1 (en) 2020-03-13
CA3003062C (en) 2019-12-31
JP5810159B2 (en) 2015-11-11
HUS2000016I1 (en) 2020-07-28
US11478487B1 (en) 2022-10-25
US20220339107A1 (en) 2022-10-27
EA201291372A1 (en) 2013-06-28
US20250213487A1 (en) 2025-07-03
CA3003062A1 (en) 2012-01-05
CY1122544T1 (en) 2021-01-27
PH12012502499A1 (en) 2013-03-25
FR22C1031I2 (en) 2023-12-22
KR20130048227A (en) 2013-05-09
RS59826B1 (en) 2020-02-28
RS63027B1 (en) 2022-04-29
AU2011273605B2 (en) 2016-05-26
KR20170085604A (en) 2017-07-24
BR112012033391A8 (en) 2018-04-17
US11951213B2 (en) 2024-04-09
EP2588114A1 (en) 2013-05-08
US11452695B2 (en) 2022-09-27
CY1125061T1 (en) 2023-06-09
LT3632448T (en) 2022-03-25
NZ605176A (en) 2015-02-27
US11504334B2 (en) 2022-11-22
EP3632448A1 (en) 2020-04-08
US20220339106A1 (en) 2022-10-27
PE20130780A1 (en) 2013-07-06
CA2803721A1 (en) 2012-01-05
PE20161410A1 (en) 2017-01-10
US20230046871A1 (en) 2023-02-16
PL2588114T3 (en) 2020-05-18
US12280151B2 (en) 2025-04-22
CA3061421A1 (en) 2012-01-05
SMT202200129T1 (en) 2022-05-12
US20220339165A1 (en) 2022-10-27
AU2011273605A8 (en) 2016-07-28
AR081670A1 (en) 2012-10-10
AU2011273605A1 (en) 2013-01-17
KR102164693B1 (en) 2020-10-13
US12090231B2 (en) 2024-09-17
EP2588114B1 (en) 2019-12-25
US20220241209A1 (en) 2022-08-04
PT3632448T (en) 2022-03-07
CA3061421C (en) 2021-06-01
PL3632448T3 (en) 2022-05-02
LTPA2022513I1 (en) 2022-07-11
EA028680B1 (en) 2017-12-29
SI3632448T1 (en) 2022-04-29
EP4056186A1 (en) 2022-09-14
EP3632448B1 (en) 2022-01-12
US20230372248A1 (en) 2023-11-23
NO2022030I1 (en) 2022-07-11
BR112012033391B1 (en) 2020-02-27
BR112012033391A2 (en) 2016-11-22
SI2588114T1 (en) 2020-07-31
WO2012000981A1 (en) 2012-01-05
JP2013529665A (en) 2013-07-22
ES2908657T3 (en) 2022-05-03
NO2020015I1 (en) 2020-06-11
US20250213488A1 (en) 2025-07-03
DK3632448T3 (en) 2022-02-07
HUS2200018I1 (en) 2022-06-28
HRP20220332T1 (en) 2022-05-13
FR22C1031I1 (en) 2022-09-09
CA2803721C (en) 2018-06-12
US20240366512A1 (en) 2024-11-07
HUE058176T2 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
FR20C1020I1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT
EP2424356A4 (en) STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USE
EP2474522A4 (en) AGOMÉLATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP2451435A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM THIOSULFATE
IL222738A0 (en) Pharmaceutical emulsion composition comprising progestogen
EP2391365A4 (en) SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND LOSARTAN
PT3222272T (en) PHARMACEUTICAL COMPOSITION OF CARBETOCIN
EP2646006A4 (en) PHARMACEUTICAL FORM
FR2948568B1 (en) PHARMACEUTICAL FORMULATION
EP2484697A4 (en) ANTIPODOPLANIN ANTIBODY AND PHARMACEUTICAL COMPOSITION CONTAINING ANTIPODOPLANIN ANTIBODY
EP2589382A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING LEVOCARNITINE AND DOBESILATE
EP2519240A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND ROSUVASTATIN
FR2958157B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING N-ACETYL-GLUCOSAMINE-6-PHOSPHATE
EP2642979A4 (en) PHARMACEUTICAL COMPOSITION
DK2542224T3 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANETEXILATE
BR112013014189A8 (en) pharmaceutical composition, use of a potentiating agent and use of a composition
EP2332535A4 (en) SOLID PHARMACEUTICAL COMPOSITION
BR112013015819A2 (en) DNA construction, pharmaceutical composition and use of a DNA construction
BRPI1006666A2 (en) "pharmaceutical composition and use of a pharmaceutical composition"
EP2666482A4 (en) PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION USING THE SAME
BR112013010709A2 (en) trans-2-decenoic acid derivative and pharmaceutical agent containing the same
EP2465512A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING PAIN
FR2958166B1 (en) PHARMACEUTICAL COMPOSITIONS HIGHLY DOSE IN BIOTIN
EP2279999A4 (en) RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
HUE054171T2 (en) Pharmaceutical compositions containing paracetamol and methods for their preparation